What is the recommended corticosteroid treatment for a pseudogout flare?

Corticosteroid Treatment for Pseudogout Flares

For acute pseudogout flares, use corticosteroids as first-line therapy with either oral prednisolone 35 mg daily for 5 days, intramuscular triamcinolone acetonide 60 mg as a single dose, or intra-articular corticosteroid injection for monoarticular disease.

Treatment Algorithm

First-Line Corticosteroid Options

The treatment approach for pseudogout mirrors that of gout, as both are crystal-induced inflammatory arthropathies. While specific pseudogout guidelines are limited, the management principles are well-established 1:

Oral corticosteroids:

• Prednisolone 35 mg daily for 5 days is the evidence-based oral regimen 1
• Should be considered first-line in patients without contraindications (systemic fungal infections, uncontrolled diabetes)
• Generally safer than NSAIDs, particularly in elderly patients with renal disease, heart failure, or cirrhosis 1

Intramuscular corticosteroids:

• Triamcinolone acetonide 60 mg IM provides excellent efficacy for pseudogout 2
• Clinical improvement typically occurs by Day 3-4 in most patients 2
• A second injection may be administered on Day 1-2 if inadequate initial response (needed in approximately 43% of patients) 2
• Particularly valuable when oral medications cannot be taken 3

Intra-articular corticosteroids:

• Preferred for monoarticular attacks 4
• Allows immediate therapeutic intervention at the time of diagnostic arthrocentesis 4
• Impractical for polyarticular disease involving multiple joints 2

When Oral Route Is Not Possible

Parenteral glucocorticoids (intramuscular, intravenous, or intra-articular) are strongly recommended over IL-1 inhibitors or ACTH for patients unable to take oral medications 3. This is based on superior efficacy, lower cost, and better tolerability compared to alternatives.

Alternative for Multiple Comorbidities

ACTH (40-80 units IV/IM/SC three times daily with tapering) represents an effective option when corticosteroids are contraindicated 5. For pseudogout specifically, all episodes resolved in an average of 4.2 days 5. However, this is not first-line due to cost and the need for multiple daily injections.

Key Clinical Considerations

Polyarticular vs. Monoarticular Disease:

• Monoarticular attacks (seen in ~71% of cases): Use intra-articular injection at time of diagnostic arthrocentesis 2, 4
• Polyarticular attacks (seen in ~29% of cases): Use systemic corticosteroids (oral or IM) as intra-articular injections become impractical 2

Common Pitfalls to Avoid:

1. Misdiagnosis as septic arthritis: Pseudogout can present with fever (50% of cases) and mental confusion, leading to unnecessary surgical intervention 4. Always perform arthrocentesis with crystal analysis before assuming infection.

2. Inadequate dosing: The 60 mg IM triamcinolone dose is evidence-based; lower doses may be insufficient 2

3. Premature discontinuation: Oral regimens should complete the full 5-day course even if symptoms improve earlier 1

Safety Profile

Corticosteroids for acute pseudogout flares are well-tolerated with short-term use 2. The brief duration (5 days oral or single IM injection) minimizes risks of dysphoria, hyperglycemia, immune suppression, and fluid retention that occur with long-term use 1. No significant toxicities were observed in the prospective triamcinolone study 2.

Corticosteroids are particularly advantageous in elderly pseudogout patients who frequently have contraindications to NSAIDs (renal disease, heart failure, GI bleeding risk) or colchicine (renal/hepatic impairment) 1, 2.